DK1296651T3 - Fremgangsmåde til fremstilling af partikler til anvendelse i et farmaceutisk præparat - Google Patents

Fremgangsmåde til fremstilling af partikler til anvendelse i et farmaceutisk præparat

Info

Publication number
DK1296651T3
DK1296651T3 DK01947612T DK01947612T DK1296651T3 DK 1296651 T3 DK1296651 T3 DK 1296651T3 DK 01947612 T DK01947612 T DK 01947612T DK 01947612 T DK01947612 T DK 01947612T DK 1296651 T3 DK1296651 T3 DK 1296651T3
Authority
DK
Denmark
Prior art keywords
particles
preparation
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
DK01947612T
Other languages
Danish (da)
English (en)
Inventor
David Alexander Vodden Morton
John Nicholas Staniforth
Rosella Musa
Original Assignee
Vectura Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0029263A external-priority patent/GB0029263D0/en
Priority claimed from PCT/GB2001/001732 external-priority patent/WO2001078694A2/en
Application filed by Vectura Ltd filed Critical Vectura Ltd
Priority claimed from PCT/GB2001/002860 external-priority patent/WO2002000197A1/en
Application granted granted Critical
Publication of DK1296651T3 publication Critical patent/DK1296651T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK01947612T 2000-06-27 2001-06-27 Fremgangsmåde til fremstilling af partikler til anvendelse i et farmaceutisk præparat DK1296651T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP00113608 2000-06-27
GB0029263A GB0029263D0 (en) 2000-11-30 2000-11-30 Method of making particles for use in a pharmaceutical composition
PCT/GB2001/001732 WO2001078694A2 (en) 2000-04-17 2001-04-17 Formulations for use in inhaler devices
PCT/GB2001/002860 WO2002000197A1 (en) 2000-06-27 2001-06-27 Method of making particles for use in a pharmaceutical composition

Publications (1)

Publication Number Publication Date
DK1296651T3 true DK1296651T3 (da) 2008-02-11

Family

ID=27223055

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01947612T DK1296651T3 (da) 2000-06-27 2001-06-27 Fremgangsmåde til fremstilling af partikler til anvendelse i et farmaceutisk præparat

Country Status (5)

Country Link
JP (1) JP5698423B2 (enExample)
AU (2) AU6926101A (enExample)
CA (1) CA2413692C (enExample)
DE (1) DE60131399T3 (enExample)
DK (1) DK1296651T3 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5288791B2 (ja) * 2005-01-28 2013-09-11 武田薬品工業株式会社 難水溶性物質含有微細化組成物
ITMI20051999A1 (it) * 2005-10-21 2007-04-22 Eratech S R L Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'
KR20130062268A (ko) * 2010-04-21 2013-06-12 키에시 파르마슈티시 엣스. 피. 에이. 정전하가 감소된 입자를 제공하는 방법
ES2814336T3 (es) * 2012-04-13 2021-03-26 Glaxosmithkline Ip Dev Ltd Partículas de agregado
PT3019153T (pt) * 2013-07-11 2018-12-04 Chiesi Farm Spa Formulação de pó seco que compreende um anticolinérgico, um corticosteroide e um beta-adrenérgico para administração por inalação
MA40910A (fr) * 2014-11-07 2017-09-12 Civitas Therapeutics Inc Poudres de rapamycine pour administration pulmonaire
WO2019009335A1 (ja) * 2017-07-04 2019-01-10 村上 正裕 微粒子の製造方法及び微粒子

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1204826B (it) * 1986-03-04 1989-03-10 Chiesi Farma Spa Composizioni farmaceutiche per inalazione
SE8603812D0 (sv) * 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
DE3917617A1 (de) * 1989-05-31 1990-12-06 Boehringer Ingelheim Kg Mikronisierte bioabbaubare partikel, verfahren zur ihrer herstellung und ihre verwendung
GB2269992A (en) * 1992-08-14 1994-03-02 Rh Ne Poulenc Rorer Limited Powder inhalation formulations
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9515182D0 (en) * 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
WO1998031346A1 (en) * 1997-01-16 1998-07-23 Massachusetts Institute Of Technology Preparation of particles for inhalation
AU749623B2 (en) * 1998-03-26 2002-06-27 Astellas Pharma Inc. Sustained release preparations
DK1131059T3 (da) * 1998-11-13 2003-06-30 Jago Res Ag Tørpulver til inhalation
GB9826783D0 (en) * 1998-12-04 1999-01-27 Scherer Ltd R P Inhalation powders
GB9827145D0 (en) * 1998-12-09 1999-02-03 Co Ordinated Drug Dev Improvements in or relating to powders

Also Published As

Publication number Publication date
DE60131399T3 (de) 2019-11-14
JP2004501183A (ja) 2004-01-15
AU6926101A (en) 2002-01-08
DE60131399D1 (de) 2007-12-27
JP5698423B2 (ja) 2015-04-08
CA2413692A1 (en) 2002-01-03
DE60131399T2 (de) 2008-04-17
AU2001269261B2 (en) 2005-11-17
CA2413692C (en) 2011-10-18

Similar Documents

Publication Publication Date Title
DK1296656T3 (da) Fremgangsmåde til fremstilling af et præparat
AU2211502A (en) Method of making particles for use in a pharmaceutical composition
DK1158992T3 (da) Anvendelse af xenon til fremstilling af et farmaceutisk præparat til behandling af neurointoksikationer
ATE279961T1 (de) Neue pharmazeutische zusammensetzung
DK1349580T4 (da) Fremgangsmåde til forbedring af stabiliteten af en farmaceutisk sammensætning
DE60142197D1 (de) Pharmazeutische Zusammensetzung
ATE404180T1 (de) Geschmacksmaskierte pharmazeutische partikel
HUP0303078A3 (en) Cyclic peptidies process for their preparation pharmaceutical compositions containing them and their use
EP1458362A4 (en) PHARMACEUTICAL COMPOSITIONS IN PARTICULAR FORM
AT7729U3 (de) Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat
DK1275387T3 (da) Fremgangsmåde til fremstilling af farmaceutiske præparater af fenofibrat med höj biologisk tilgængelighed
DK1383482T3 (da) Fremgangsmåde til fremstilling af en farmaceutisk lavdoseringssammensætning
DK1309545T3 (da) Fremgangsmåde til fremstilling af alkylarylsulfonater
HUP0302130A3 (en) Combination pharmaceutical compositions and process for their preparation
HUP0300539A3 (en) New pharmaceutical composition in form of emulsion preconcentrate
DE60129238D1 (de) Pharmazeutische zusammensetzung
ATE350016T1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
DK1296651T3 (da) Fremgangsmåde til fremstilling af partikler til anvendelse i et farmaceutisk præparat
DK1326836T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
ATE222586T1 (de) Benzolsulfonamidderivate und verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
NO20030156D0 (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
DK1171444T3 (da) Pyridothienodiazepiner, fremgangsmåde til fremstilling af disse og farmaceutiske præparater indeholdende disse
IL153897A0 (en) Pharmaceutical compositions and methods for use
DK0831820T3 (da) Oral farmaceutisk sammensætning af piperidinoalkanolforbindelser på opløsningsform
EE200100607A (et) Farmatseutiline kompositsioon granulaadi kujul jaselle valmistamismeetod